Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 5Lymphoid 3Genitourinary 3Breast 3Other solid neoplasm 2Other hematologic neoplasm 2Gynecologic 2Plasma cell 1Gastrointestinal 1

Conditions

Malignant Solid Neoplasm 1Hematopoietic and Lymphatic System Neoplasm 1

Interventions

Injections 54pembrolizumab 40Carboplatin 20Bevacizumab 19Cyclophosphamide 17toripalimab 14Nivolumab 14Cisplatin 14tislelizumab 13fludarabine 13Specimen Handling 13Paclitaxel 13Interviews as Topic 13Pemetrexed 12Standard of Care 11Practice Guidelines as Topic 11Oxaliplatin 11Fluorouracil 10Cetuximab 10atezolizumab 9Educational Status 9Docetaxel 9Capecitabine 9Leucovorin 8Methods 7Etoposide 7Early Intervention, Educational 7spartalizumab 6olaparib 6Ipilimumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Exercise Test × Other solid neoplasm × Clear all
NCT06565260 2026-05-05

Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors

Roswell Park Cancer Institute

Phase NA Recruiting
150 enrolled
Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT06306638 2026-04-06

Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction

Roswell Park Cancer Institute

Phase 1/2 Recruiting
42 enrolled
Other solid neoplasm

Malignant Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡